2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …

M Glikson, JC Nielsen, MB Kronborg, Y Michowitz… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …

The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action

E Marijon, K Narayanan, K Smith, S Barra, C Basso… - The Lancet, 2023 - thelancet.com
Despite major advancements in cardiovascular medicine, sudden cardiac death (SCD)
continues to be an enormous medical and societal challenge, claiming millions of lives …

Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: a joint position statement from the Heart Failure …

W Mullens, A Auricchio, P Martens… - European journal of …, 2020 - Wiley Online Library
Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart
failure with reduced ejection fraction and leads to improved quality of life, reductions in heart …

[HTML][HTML] Artificial intelligence in ventricular arrhythmias and sudden death

L Holmström, FZ Zhang, D Ouyang, D Dey… - Arrhythmia & …, 2023 - ncbi.nlm.nih.gov
Sudden cardiac arrest due to lethal ventricular arrhythmias is a major cause of mortality
worldwide and results in more years of potential life lost than any individual cancer. Most of …

Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure—DANISH-MRI

MB Elming, S Hammer-Hansen, I Voges, E Nyktari… - American Heart …, 2020 - Elsevier
Aims Patients with non-ischemic systolic heart failure have an increased risk of sudden
cardiac death (SCD). Myocardial fibrosis, detected as late gadolinium enhancement (LGE) …

Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure …

W Mullens, A Auricchio, P Martens, K Witte… - EP …, 2021 - academic.oup.com
Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart
failure with reduced ejection fraction and leads to improved quality of life, reductions in heart …

Time-trend treatment effect of cardiac resynchronization therapy with or without defibrillator on mortality: a systematic review and meta-analysis

B Veres, P Fehérvári, MA Engh, P Hegyi… - Europace, 2023 - academic.oup.com
Aims This study aimed to investigate the impact of cardiac resynchronization therapy with a
defibrillator (CRT-D) on mortality, comparing it with CRT with a pacemaker (CRT-P) …

Survival after cardiac resynchronization therapy: results from 50 084 implantations

F Leyva, A Zegard, O Okafor, J De Bono… - EP …, 2019 - academic.oup.com
Aims Randomized controlled trials have shown that cardiac resynchronization therapy
(CRT) prolongs survival in patients with heart failure. No studies have explored survival after …

Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy

F Leyva, A Zegard, F Umar, RJ Taylor, E Acquaye… - EP …, 2018 - academic.oup.com
Aims There is a continuing debate as to whether cardiac resynchronization therapy-
defibrillation (CRT-D) is superior to CRT-pacing (CRT-P), particularly in patients with non …

Cardiac resynchronization therapy with or without defibrillator in patients with heart failure

B Schrage, LH Lund, M Melin, L Benson, A Uijl… - EP …, 2022 - academic.oup.com
Aims Randomized data on the efficacy/safety of cardiac resynchronization therapy with vs.
without defibrillator (CRT-D,-P) in heart failure with reduced ejection fraction (HFrEF) are …